Nurofen is the best-selling analgesics brand, with a 15.8% market share, as much as the next two competitors together. The second leading brand is Aspenter (aspirin) made by Terapia Cluj, the local plant held by India’s Sun Pharma, 7.9% market share.

“Analgesics is a large and diverse category in Romania and demand is (…) sustained by a high level of self-medication among consumers,” Euromonitor analysts say. Thus, positive growth of such drugs is likely to keep being supported by heavy advertising, they added.

UK’s Reckitt Benckiser, the maker of Nurofen, posted more than  RON562 million sales in 2018, up 23% on the previous year, according to Finance Ministry data. The company also sells Strepsils (for sore throat) and Gaviscon in Romania.

The other favorite brands of Romanian consumers are Aspenter, and Antinevralgic P (Sanofi), 7.7% market share. The other top five brands are GSK’s Panadol and Bayer’s Bayer Aspirin. The top five brands account for 40% of the analgesics market together.

(English version by Loredana Fratila-Cristescu)